Drugs / 123-I AV94
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00605059 | Aug 2007 → Jun 2008 | Alzheimer disease | Institute for Neurodegenerative Disorders | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 123-I AV94 | “Subjects will be asked to undergo a bolus injection of 123-I AV94.” NCT00605059 ↗ |
| Modality | Diagnostic / imaging agent | “123-I AV94 as a single photon computed tomography (SPECT) brain imaging agent” NCT00605059 ↗ |